Emiliano Barbieri

ORCID: 0000-0003-3148-6608
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Myeloma Research and Treatments
  • Peptidase Inhibition and Analysis
  • Protein Degradation and Inhibitors
  • Lymphoma Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Chronic Lymphocytic Leukemia Research
  • Liver Disease Diagnosis and Treatment
  • Diet and metabolism studies
  • Patient-Provider Communication in Healthcare
  • Acute Lymphoblastic Leukemia research
  • Pancreatic function and diabetes
  • Clinical Reasoning and Diagnostic Skills
  • Acute Myeloid Leukemia Research
  • Ovarian cancer diagnosis and treatment
  • CNS Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Metabolism, Diabetes, and Cancer
  • Respiratory viral infections research
  • Advanced Power Generation Technologies
  • Optical Polarization and Ellipsometry
  • Hematopoietic Stem Cell Transplantation
  • Cancer Immunotherapy and Biomarkers
  • Cancer Treatment and Pharmacology
  • Congenital Diaphragmatic Hernia Studies
  • Healthcare professionals’ stress and burnout

University of Modena and Reggio Emilia
2020-2025

Azienda Sanitaria Unità Locale di Reggio Emilia
2024-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2024-2025

Santobono Children's Hospital
2025

University of Naples Federico II
2023-2024

Federico II University Hospital
2023

Azienda Ospedaliero-Universitaria di Modena
2022

ORCID
2020

Abstract Background Breaking bad news (BBN) may be associated with increasing risk of burnout in practising physicians. However, there is little research on the association between way broken and burnout. We investigated physicians’ self-efficacy regarding communication to patients Methods performed a cross-sectional study by proposing an ad-hoc survey exploring attitudes practice BBN Maslach Burnout Inventory - Human Service Survey 379 physicians from two University Hospitals Italy....

10.1186/s12955-020-01504-y article EN cc-by Health and Quality of Life Outcomes 2020-08-06

ABSTRACT This multicenter real‐world analysis evaluated the efficacy of isatuximab, pomalidomide, and dexamethasone (IsaPd) in 51 patients with multiple myeloma (MM) who were refractory to daratumumab (Dara‐R). The majority under 70 years old (60.8%), predominantly female (56.9%), heavily pretreated, 74.5% being triple‐class (TCR); 32.1% 28 cytogenetic data had high‐risk abnormalities. overall response rate (ORR) was 56.9%, including 3 stringent complete (sCR), 4 CR, 7 very good partial...

10.1002/hon.70042 article EN cc-by Hematological Oncology 2025-02-03

ABSTRACT Relapsed/refractory multiple myeloma (RRMM) research on the impact of +1q abnormalities in real‐world settings is limited. This study evaluated prognostic and predictive significance 1q gain [gain(1q)] amplification [ampl(1q)] 635 RRMM patients treated with daratumumab‐, elotuzumab‐, carfilzomib‐based triplet regimens. Patients had lower deep response rates [≥ CR: 9.4% for gain(1q), 11.6% ampl(1q)] versus 20.2% +1q‐negative patients. Multivariable ordinal logistic analysis showed...

10.1111/ejh.14413 article EN cc-by European Journal Of Haematology 2025-03-19

Abstract The ELOQUENT‐3 trial demonstrated the superiority of combination elotuzumab, pomalidomide, and dexamethasone (EloPd) in terms efficacy safety, compared to Pd relapsed/refractory multiple myeloma (RRMM), who had received at least two prior therapies, including lenalidomide a proteasome inhibitor. present study is an 18‐month follow‐up update previously published Italian real‐life RRMM cohort patients treated with EloPd. This revised analysis entered 319 accrued 41 centers. After...

10.1002/hon.3290 article EN Hematological Oncology 2024-05-31

Not available.

10.3324/haematol.2024.286658 article EN cc-by-nc Haematologica 2024-11-28

Chronic lymphocytic leukemia (CLL), the most common in western countries, is characterized by immunosuppression due to disease itself and cytotoxic treatments. Since beginning of COVID-19 pandemic, patients with CLL appear be a vulnerable population. In addition, phase III mRNA vaccine trials did not provide information about efficacy immunocomprised CLL, antibody-mediated response SARS-CoV-2 impaired. The goal this study was evaluate effects vaccination on humoral immune cellular immunity...

10.1002/hon.3077 article EN cc-by-nc-nd Hematological Oncology 2022-09-26

Abstract Aim In this study, we investigated glucose and lactate kinetics during a 75 g oral tolerance test (OGTT) in 23 overweight obese adolescents assessed putative differences among participants with without metabolic dysfunction‐associated steatotic liver disease (MASLD). Methods We enrolled young people (six girls) obesity [body mass index 33 (29‐37)]. Glucose‐lactate parameters (disposal insulin sensitivity, SI D ; fraction of converted into lactate, fr; fractional clearance rate, k L...

10.1111/dom.15648 article EN Diabetes Obesity and Metabolism 2024-05-14

The treatment choice for an older patient with diffuse large B-cell lymphoma (DLBCL) depends on many other factors in addition to age, which alone does not reflect the complexity of aging process. Functional features and comorbidity incidence differ only between younger patients but also among themselves. comprehensive geriatric assessment (CGA) quickly evaluates fitness status by investigating patient's different functional areas, degree autonomy, presence comorbidities. Various tools are...

10.3390/cancers15245845 article EN Cancers 2023-12-14

Importance Pediatric obesity is a growing health care burden. Understanding how the metabolic phenotype of youth with may modify effect intestinal fermentation on human metabolism key to designing early intervention. Objective To assess whether adiposity and insulin resistance in be associated colonic dietary fibers its production acetate, gut-derived hormone secretion, adipose tissue lipolysis. Design, Setting, Participants Cross-sectional study youths aged 15 22 years body mass index 25th...

10.1001/jamanetworkopen.2023.12530 article EN cc-by-nc-nd JAMA Network Open 2023-05-09

Pediatric obesity is associated with insulin resistance, which, in turn, impacts glucose and lipid metabolism. This study sought to assess how variability relates intrahepatic fat content, β cell sensitivity, glycolysis youth obesity.

10.1002/oby.24175 article EN Obesity 2024-12-10

Abstract Background: Breaking bad news (BBN) may be associated with increasing risk of burnout in practising physicians. However, there is little research on the association between way broken and burnout. We investigated physicians' self-efficacy regarding communication to patients Methods: performed a cross-sectional study by proposing an ad-hoc survey exploring attitudes practice BBN Maslach Burnout Inventory - Human Service Survey 379 physicians from two University Hospitals Italy....

10.21203/rs.2.23481/v2 preprint EN cc-by Research Square (Research Square) 2020-07-16
Coming Soon ...